Huadong Medicine (000963.SZ) Earnings Analysis

Huadong Medicine (000963.SZ) next reports earnings on 2026-08-27, consensus EPS 0.586 CNY. Last quarter (2026-04-24) it missed with EPS 0.514 CNY vs 0.535 CNY est (-3.9%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E 15.27.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 000963.SZ next report earnings?

Next earnings date2026-08-27
Consensus EPS estimate0.586 CNY
Revenue estimate11.46B

000963.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-240.514 CNY0.535 CNY-3.9%Miss
2026-04-230.571 CNY0.62 CNY-7.9%Miss
2025-10-270.532 CNY0.532 CNY0%Beat
2025-08-190.509 CNY0.4994 CNY+1.9%Beat
2025-04-240.52 CNY0.52 CNY0%Beat
2024-12-310.542 CNYn/an/an/a
2024-10-240.5 CNY0.48 CNY+4.2%Beat
2024-08-150.48 CNY0.45 CNY+6.7%Beat

Beat rate: 5/7 (71%) over reported quarters with consensus data.

000963.SZ valuation and analyst view

Trailing P/E15.27
Trailing EPS1.997 CNY
Price / book2.07
Dividend yield3.06%
Market cap54.02B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Huadong Medicine (000963.SZ)'s next earnings date?

Huadong Medicine is next scheduled to report on 2026-08-27, with a consensus EPS estimate of 0.586 CNY and revenue estimate of 11.46B.

Did 000963.SZ beat earnings last quarter?

In its 2026-04-24 report, 000963.SZ posted EPS of 0.514 CNY versus a 0.535 CNY estimate — a miss of 3.9%.

What is 000963.SZ's earnings track record?

Over the last 7 reported quarters with consensus data, 000963.SZ beat estimates 5 times (71%).

What is 000963.SZ's current P/E ratio and EPS?

000963.SZ trades at a trailing P/E of 15.27 on trailing EPS of 1.9967740319726692 CNY.

What do analysts rate 000963.SZ?

000963.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.